Evaluation of the Pharmaceutical Drugs Program / prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. : H14-620/2024E-PDF
"Covering activities from 2017-18 to 2022-23, the evaluation examined pharmaceutical drugs for human and veterinary use, including both prescription and non-prescription drugs. Activities related to biologics, radiopharmaceuticals, natural health products and medical devices were excluded from this evaluation, as there are separately planned evaluations to assess these other health products"--page iii.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.939161&sl=1
| Ministère/Organisme | Canada. Health Canada, issuing body. Public Health Agency of Canada, issuing body. |
|---|---|
| Titre | Evaluation of the Pharmaceutical Drugs Program / prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Issued also in French under title: Évaluation du Programme des médicaments pharmaceutiques. Includes bibiographical references (pages [pages 8-11]). |
| Information sur la publication | [Ottawa] : Health Canada, Public Health Agency of Canada = Santé Canada, l'Agence de la santé publique du Canada, January 2024. ©2024 |
| Description | 1 online resource (ii, vi, 38, [11] pages) : charts |
| ISBN | 9780660722801 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | 240263 |
| Descripteurs | Canada. Health Canada -- Evaluation. Public Health Agency of Canada -- Evaluation. Pharmaceutical policy -- Canada -- Evaluation. |